Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist
ChemBioChem - Germany
doi 10.1002/cbic.201402077
Full Text
Open PDFAbstract
Available in full text
Date
May 30, 2014
Authors
Publisher
Wiley